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AbSTRACT
Purpose: Clinical and endoscopic assessment of the outcome after fundoplication for 
pediatric gastroesophageal reflux.
Basic procedures: Hospital records of 279 consecutive patients who underwent 
fundoplication for gastroesophageal reflux from 1991 to 2014 were reviewed. Underlying 
disorders, clinical and endoscopic findings, imaging studies, pH monitoring, and surgical 
technique were assessed. Main outcome measures were patency of fundoplication, control 
of symptoms and esophagitis, complications, redo operations, and predictive factors of 
failures.
Main results: A total of 279 patients underwent 300 fundoplications (277 primaries and 
23 redos). Underlying disorders in 217 (72%) patients included neurological impairment 
(28%) and esophageal atresia (22%). Indications for fundoplication included recalcitrant 
gastroesophageal reflux symptoms (44%), failure to thrive (22%), respiratory symptoms 
(15%), esophageal anastomotic stricture (4%), apneic spells (2%), and regurgitation (2%). 
Preoperative endoscopy was performed in 92% and pH monitoring in 49% of patients. 
Median age at primary fundoplication was 2.2 ((IQR = 0.5–7.5)) years. Fundoplication 
was open in 205 (74%; Nissen n = 63, boix-Ochoa n = 97, Toupet n = 39, and other n = 6), 
laparoscopic in 72 (24%; Nissen n = 67 and Toupet n = 5), and included hiatoplasty in 
73%. Clinical follow-up was a median of 3.9 (IQR = 1.2–9.9) years. Mortality related to 
surgery was 0.3%. Symptom control was achieved in 87% of patients, and esophagitis 
rate decreased from 65% to 29% (p < 0.001). Fundoplication failed in 41 (15%) patients. 
Failure was predicted by esophageal atresia risk ratio = 3.9 (95% confidence interval = 1.3–
11, p = 0.01), any underlying disorder risk ratio = 3.1 (95% confidence interval = 1.1–9.1, 
p = 0.04), and hiatoplasty risk ratio = 2.6 (95% confidence interval = 1.1–6.6, p = 0.03). Of the 
23 redo-fundoplications, 32% failed.
Correspondence:
Antti I. Koivusalo, MD, Ph.D.  
Section of Paediatric Surgery  
Children’s Hospital  
Helsinki University Hospital  
Stenbackinkatu 11 
00290 PL 281 Helsinki  
Finland 
Email: antti.koivusalo@hus.fi
698641 SJS0010.1177/1457496917698641A. I. Koivusalo, M. P. Pakarinen Scandinavian Journal of Surgery
research-article2017
Original Research Article
Outcome of surgery for pediatric gastroesophageal reflux 69
Conclusion: The majority of patients who underwent fundoplication had an underlying 
disorder. Primary fundoplication provided control of symptoms in almost 90% of patients 
and also reduced the rate of esophagitis. Failure of primary fundoplication occurred in 
15% of patients, and an underlying disorder, esophageal atresia, and hiatoplasty increased 
the risk of failure.
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InTRODUCTIOn
In children, gastroesophageal reflux disease (GERD) 
may cause severe problems of nutrition, growth, and 
respiratory function (1). In the management of con-
genital malformations such as esophageal atresia 
(EA), laryngotracheal anomalies, and congenital dia-
phragmatic hernia (CDH), control of GERD is of para-
mount importance(2). Abnormal esophageal anatomy 
and function, such as short dysmotile esophagus in 
EA, lack of diaphragmatic muscular support of the 
esophagogastric region in CDH, and abnormal neural 
regulation and impaired esophageal motility in neuro-
logical diseases, predisposes to severe GERD, which 
cannot be controlled by conservative measures, and 
surgical management is required (2). Although sur-
gery effectively controls GERD, long-term complica-
tions such as recurrence of GERD, retching, or 
dysphagia are not uncommon (2–4).
In this retrospective study, we investigated the out-
come of 300 consecutive fundoplications for pediatric 
GERD in a national tertiary pediatric surgical center 
from 1991 to 2014. We analyzed operative complica-
tions, surgical failures, redo operations, and their pre-
dictive factors.
METHODS
The hospital review board approved this study. 
Hospital records of 279 consecutive patients who 
underwent fundoplication for GERD in our institution 
during the 24-year period from 1991 to 2014 were 
completely reviewed. Surgical technique, preopera-
tive and postoperative endoscopic findings, imaging 
studies, results of esophageal pH monitoring, clinical 
symptoms, and medication were carefully assessed.
The main indication for fundoplication was compli-
cated GERD unmanageable with conservative treat-
ment. The complications included failure to thrive, 
chronic respiratory problems, aspiration, apneic 
spells, esophageal stricture, persisting reflux esophagi-
tis, and uncontrollable gastroesophageal reflux (GER) 
symptoms. Whenever clinically possible, conservative 
treatment was first attempted. Conservative treatment 
of GERD included prone positioning, thickening of 
feeds and continuous tube feeding via nasogastic 
tube, gastrostomy or (transgastric) jejunostomy with 
or without oral proton pump inhibitors (1–2 mg/kg 
daily), ranitidine (5 mg/kg in two daily doses), or 
cisapride (1 mg/kg in three daily doses).
Preoperative upper gastrointestinal endoscopy and 
24-h esophageal pH monitoring or pH-impedance 
monitoring were performed when clinically applica-
ble to provide supporting data for the decision to per-
form surgery. Endoscopies were performed with 
flexible videogastroscope (Pentax EG 2985, Japan). 
Esophagitis was graded histologically as none, mild, 
moderate, or severe. Of the metaplastic changes, only 
intestinal metaplasia (columnar epithelium and goblet 
cells) was recorded (5, 6). Esophageal pH monitoring 
showing acidic reflux over 10% of the total measure-
ment time or 5% of total time minus 2 h after meals or 
reflux periods exceeding 5 min (7) or moderate or 
severe histological esophagitis was considered indica-
tive of significant GERD. Preoperative upper gastroin-
testinal tract contrast study was routinely performed 
to exclude a small intestinal obstruction, whereas 
reflux of contrast into the esophagus was not consid-
ered diagnostic for GERD. Esophageal manometry or 
gastric emptying studies were performed selectively. 
In otherwise healthy children, socially restricting 
regurgitation unresponsive to anti-reflux medication 
was considered an indication for fundoplication, 
although endoscopy and pH monitoring in these 
patients were generally normal.
The most common surgical techniques for abdomi-
nal fundoplication were nissen, Toupet (2), and Boix-
Ochoa (8) and for thoracic fundoplication was Belsey 
Mark IV (9). Laparoscopic fundoplications were 
started in 1998. In patients without endoscopic or 
radiologic evidence of hiatal hernia, routine hiato-
plasty in transabdominal fundoplications was aban-
doned in 2007.
Postoperative weaning from anti-reflux medication 
was individualized. Patients with EA underwent a pro-
grammed endoscopic surveillance from 1 to 15 years of 
age. Preoperative esophageal pathology, such as mod-
erate or severe esophagitis, stricture, or hiatal hernia, 
warranted routine postoperative endoscopic surveil-
lance also in other patients. Other indications for post-
operative endoscopy, contrast study, or pH monitoring 
included dysphagia and recurrence of any symptoms 
or complications of GERD after surgery.
In follow-up endoscopy, patency of the fundoplica-
tion was assessed by antegrade viewing of the gas-
troesophageal junction and retrograde viewing of 
the fundoplication wrap at esophagogastric junction 
by inverting the gastroscope in air-filled stomach. 
Signs of failed fundoplication included loose or absent 
wrap, wrap retraction into thorax, or hiatal and parae-
sophageal hernias (10). Esophagitis was assessed his-
tologically. Persisting moderate or severe postoperative 
esophagitis—after fundoplication with anti-reflux 
medication—was considered as a treatment failure. 
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Mild esophagitis, a very common finding in GERD, 
was not considered significant.
The main outcome measure was the patency of fun-
doplication classified according to the last recorded 
clinical or endoscopic assessment as “fundoplication 
intact” or “fundoplication failed.” Clinical outcome 
was classified as good (full resolution of symptoms), 
moderate (attenuation of symptoms but some com-
plaints), or poor (inadequate response).
STATISTICAL AnALySES
Statistical analyses were performed with StatView® 
512 program (Calabasas, CA, USA). Unless otherwise 
stated, the data are presented as medians and inter-
quartile range (IQR) or as frequencies. The effects of 
various factors on outcome were assessed by a logistic 
regression analysis. Frequencies were compared with 
Fisher’s exact test. Values of p < 0.05 were considered 
statistically significant.
RESULTS
A total of 279 consecutive patients (155 males) were 
included. We performed primary fundoplication in 
277 patients, 2 patients were referred for a re- 
fundoplication. Underlying conditions are classified 
in Table 1. Syndromes and associated disorders 
included arthrogryposis (n = 1), Asperger (n = 2), 
CATCH 22 (n = 2), Charcot–Marie Tooth (n = 1), 
CHARGE (coloboma, heart defects, atresia choanae, 
growth retardation, genital abnormalities, and ear 
abnormalities) (n = 9), Cornelia de Lange (n = 3), Cri 
du Chat (n = 1), Crouzon (n = 1), Down (n = 6), 
Ehlers–Danlos (n = 1), Goldenhar (n = 1), Kabuki 
(n = 1), Langer-Giedion (n = 1), Leigh (n = 1), Moebius 
(n = 2), nager (n = 1), noonan (n = 1), Pierre Robin 
(n = 2), Tourette (n = 1), Townes–Brock (n = 1), Turner 
(n = 2), VACTERL (vertebral defects, anal atresia, car-
diac defects, tracheoesophageal fistula, renal anom-
alies, and limb abnormalities) (n = 20), and Williams 
(n = 1).
FUnDOPLICATIOnS
A total of 277 patients underwent primary fundopli-
cation. Of the 277 patients, 19 (7%) underwent redo-
fundoplication—18 in our center and 1 after transition 
in an adult center. In addition, two patients who 
underwent the primary operation elsewhere were 
referred for redo-fundoplication (eventually, one 
patient underwent one and the other four redo-fun-
doplications). Total number of fundoplications was 
300 (277 primaries and 23 redo-fundoplications). 
Median age at primary fundoplication was 2.2 
(IQR = 0.5–7.5) years.
Only 22% of the patients were otherwise healthy, 
whereas the most common underlying conditions 
included neurological impairment (nI; 28%) and EA 
(23%). The main indications for fundoplication are 
given in Table 2. Patients with EA underwent fun-
doplication earlier, at median age of 5.0 (IQR = 3.0–28) 
months, compared with other children (36 (IQR = 9.3–
103) months, p < 0.001). Healthy children underwent 
fundoplication at a later age of 5.9 (IQR = 2.5–10) years 
compared to the rest, 1.4 (IQR = 0.4–5.9) years, 
p < 0.001). Of the 111 primary fundoplications per-
formed before the age of 12 months, only 10 (9%) were 
performed in healthy children for the following indi-
cations: failure to thrive n = 2, reflux symptoms n = 3, 
and apneic episodes n = 5.
Of the 279 patients who underwent fundoplication, 
254 (91%) underwent preoperative endoscopy. Mild 
(n = 66, 29%), moderate (n = 65, 29%), or severe (n = 15, 
7%) histological esophagitis was found in 200 (72%) 
patients, and intestinal metaplasia in one. Other sig-
nificant findings included anastomotic stricture after 
repair of EA (n = 24), peptic stricture (n = 1), hiatal her-
nia (n = 6), paraesophageal hernia (n = 2), and failed 
primary fundoplication (n = 2, in two referred patients). 
Esophageal pH monitoring or pH-impedance moni-
toring showed pathological acid reflux in 137 patients; 
in addition, impedance monitoring showed impaired 
esophageal clearance in six patients with EA. Six 
patients underwent biphasic isotope test for gastric 
emptying with normal results; no preoperative esoph-
ageal manometries were done.
Types of primary fundoplications (n = 277) were 
nissen (n = 63), laparoscopic nissen (n = 67), Boix-
TABLE 1
Underlying diagnosis in 279 pediatric patients who underwent 
fundoplication for GERD.
Fundoplication: Total 279 (100%)
neurological impairment 72 (26%)
Esophageal atresia 64 (23%)
Respiratory disorder 22 (7.9%)
Heart disease only 16 (5.7%)
Duodenal atresia 13 (4.7%)
Congenital diaphragmatic hernia/diaphragmatic 
eventration
12 (4.3%)
Prematurity 9 (3.2%)
Achalasia cardiae 4 (1.4%)
Tracheoesophageal cleft (type IV) 3 (1.1%)
Scleroderma 1 (0.4%)
Omphalocele 1 (0.4%)
Healthy 62 (22%)
GERD: gastroesophageal reflux disease.
TABLE 2
Indications for primary fundoplication in 277 pediatric patients.
Recalcitrant GER symptoms 122 (44%)
Failure to thrive 60 (22%)
Respiratory symptoms 43 (15%)
Recurring stricture of esophageal anastomosis 24 (4%)
Regurgitation 12 (2%)
Apneic spells 12 (2%)
 Esophageal atresia (5) 5
  Pierre Robin syndrome, CATCH 22, and 
cerebral palsy (3)
3
 Healthy (4) 4
Fundoplication in Heller’s myotomy for 
achalasia cardiae
4
GER: gastroesophageal reflux.
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Ochoa (n = 97), Toupet (n = 39), laparoscopic Toupet 
(n = 5), transthoracic Belsey Mark IV (n = 3), or other 
(Thal, Collis n = 3). Open technique was used in 205 
(74%) operations (including 3 operations converted 
from laparoscopic to open) and laparoscopic in 72 
(26%). Hiatoplasty was performed in 170 (83%) of the 
205 open operations and in 31 (43%) of the 72 laparo-
scopic operations (p < 0.001).
Feeding gastrostomy was inserted to 94 (34%) 
patients before (n = 40), at the time (n = 45), or after 
(n = 9) fundoplication. Temporary detachment of a 
previously constructed gastrostomy was required in 
five operations. Gastrostomy was most common (53%) 
in patients with nI or cardio-respiratory disorders.
From the start of laparoscopic fundoplications in 
1998, we performed a total of 172 fundoplications, 
including 72 (42%) laparoscopic and 100 (58%) open 
procedures. Laparoscopic fundoplication was favored 
in healthy patients (25/41) in relation to patients with 
an underlying condition (47/131), p = 0.01.
FOLLOW-UP AFTER FUnDOPLICATIOnS
Of the 279 patients, 31 (11%) died after a median fol-
low-up of 3.2 (IQR = 0.5–9.5) years. Fundoplication-
related death occurred in one case due to sequelae 
after post-fundoplication small bowel strangulation. 
Other non-survivors included patients with EA (n = 6), 
tracheoesophageal cleft (n = 1), duodenal atresia with 
Down’s syndrome (n = 2), CDH (n = 2), cerebral palsy 
(n = 14), and heart disease (n = 5). Of the 279 patients, 
10 (2%) were lost to follow-up. Clinical follow-up data 
of the remaining 269 patients were available, and in 
75% of these, follow-up exceeded 12 months. 
Endoscopic follow-up data included 240 of 269 (85%) 
patients and exceeded 12 months in 180 of 240 (75%). 
Because of anastomotic complications, two patients 
with EA underwent esophageal replacement, and a 
patent fundoplication was surgically removed.
Median clinical follow-up after primary fundopli-
cation was 3.9 (IQR = 1.2–9.9) years. Control of GERD 
symptoms was good in 219 (81%), moderate in 26 
(10%), and poor in 24 (9%) patients. In 20 patients 
with good (n = 19) or moderate (n = 1) control of 
GERD symptoms, functional problems (frequent 
vomiting n = 6, dysphagia n = 8, inability to burp and 
vomit n = 5, slow gastric emptying n = 1) had mild 
(n = 15) or moderate (n = 5) negative effect on general 
outcome. At the time of latest follow-up visit, 77 
(29%) of the 269 patients used protein pump inhibi-
tors for anti-reflux medication. In five patients, the 
preoperative diagnosis of GERD changed to cyclic 
vomiting (n = 1), esophageal dysmotility (n = 3), and 
eosinophilic esophagitis (n = 2).
Endoscopic follow-up was performed in 240 (96%) 
of 269 patients. Median follow-up after primary fun-
doplication was 2.7 (IQR = 0.9–7.5) years with a median 
of 2 (IQR = 1–3) endoscopies per patient. Comparison 
between preoperative and postoperative biopsies was 
possible in 193 patients. The overall occurrence of 
esophagitis (mild, moderate, and severe) decreased 
from 65% to 29% (p < 0.001) and of moderate or severe 
esophagitis from 36% to 9% (p < 0.001). Postoperative 
endoscopy displayed no or mild histological esophagi-
tis in 171 (90%) patients. Unhealed or recurred (mod-
erate or severe) esophagitis was observed in 20 (10%) 
patients. Preoperatively, three patients had pathologic 
pH monitoring and histologically verified moderate 
esophagitis with some eosinophil leucocytes consist-
ent with reflux esophagitis but not responding to pro-
ton pump inhibitors. Postoperative biopsies at 
6 months still showed moderate esophagitis but with 
high amount of eosinophils (>50 eosinophils/micro-
scopic field) consistent with eosinophilic esophagitis. 
In two patients, eosinophilic esophagitis was associ-
ated with dysphagia, and with oral fluticasone, dys-
phagia and eosinophilic esophagitis disappeared, 
whereas in the third non-symptomatic patient, eosino-
philic inflammation disappeared without treatment. 
Five patients (2%), two with EA, one with nI, and two 
healthy patients—one with pre-fundoplication peptic 
esophageal stricture and the other with failed fun-
doplication and recalcitrant moderate esophagitis—
developed intestinal metaplasia after 14 (IQR 12–18) 
postoperative years; all five were programmed for fur-
ther endoscopic surveillance.
Endoscopic diagnosis of failed fundoplication was 
made in 38 (16%) patients. Findings included totally 
loosened wrap (n = 28), wrap retraction into thorax 
(n = 7), hiatal hernia (n = 3), and paraesophageal hernia 
(n = 1).
COMPLICATIOnS AFTER FUnDOPLICATIOnS
Three patients were reoperated for small bowel stran-
gulation (n = 1) and adhesive obstruction (n = 2). Two 
patients had gastric retention exceeding 1 week after 
fundoplication. An attempt to relieve pyloric spasm 
by endoscopic balloon dilatation resulted in gastric 
perforation, and both patients underwent emergency 
laparotomy and suture closure of perforations.
Postoperative endoscopic balloon dilatations of the 
fundoplication wrap were performed in 11 (5%) of 
205 patients of whom 8 had persistent dysphagia and 
3 a disturbing inability to burp and vomit after 
nissen-type fundoplication. Three patients with dys-
phagia benefited from dilatations. In two patients 
with unsuccessful dilatations, esophageal biopsies 
indicated eosinophilic esophagitis and dysphagia 
attenuated after a course of oral fluticasone 250 mg 
daily. In three remaining patients with recalcitrant 
postoperative dysphagia, esophageal manometry 
showed impaired motility of the esophageal body, 
and in them, dysphagia attenuated with oral cisap-
ride (5–10 mg three times daily).
FAILED PRIMARy FUnDOPLICATIOnS
Of the 269 patients with follow-up data, primary fun-
doplication eventually failed in 41 (15%). Median time 
to failure was 3.0 (IQR = 0.7–11) years. Cumulative fail-
ure rate at 5 and 10 years were 86% and 83% (Fig. 1). 
Failures were diagnosed by recurrent symptoms com-
bined with endoscopy in 38 or contrast imaging in 2 
patients. The failure rate was highest in patients with 
EA (16/64, 25%) compared with other patients 
(25/205, 12%; p = 0.02), whereas the respective median 
lag times of 3.9 (IQR = 0.8–13) and 3.0 (IQR = 0.7–8.0) 
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years from fundoplication to failure were similar 
(p = 0.61). Long-term failure rate in patients with any 
underlying disease (n = 209) or with EA or nI (n = 128) 
was higher than in otherwise healthy patients (n = 60), 
but the difference was not statistically significant (Figs 
2 and 3). Of the 41 patients with failed primary fun-
doplication, 18 (44%) eventually underwent redo-fun-
doplication. In 23 patients, redo-fundoplication was 
not performed for the following reasons: mild GER 
symptoms (n = 7), GER symptoms managed with 
medication (n = 10), poor general condition (n = 2), and 
deceased (n = 4).
REDO-FUnDOPLICATIOnS
We performed a total of 23 redo-fundoplications in 20 
patients. One patient underwent four redo-fundoplica-
tions. Preoperative diagnostics included endoscopy 
(n = 19), pH monitoring (n = 11), and contrast study 
(n = 7). Indications for redo-fundoplications were failed 
primary fundoplication in 20 patients, the primary 
fundoplication of whom was performed in our center 
in 18 and 2 referred patients; 1 patient required 3 fur-
ther redo-fundoplications. Median age at redo- 
fundoplication was 2.2 (IQR = 1.1–5.1) years, and 
median delay after the primary fundoplication was 11 
(IQR = 7–33) months. All the 20 patients had an under-
lying disorder, including EA (n = 7) with redo rate of 
7/64 (11%), nI (n = 6) with redo rate of 6/64 (9%), iso-
lated heart disease (n = 2), respiratory disorder (n = 2), 
and tracheoesophageal cleft type IV, impaired esopha-
geal motility, and prematurity one each.
Redo-fundoplication techniques were open nissen 
(n = 11), laparoscopic nissen (n = 1), Thal (n = 1), and 
Belsey Mark (n = 7). One patient underwent three fur-
ther re-operations with open nissen (n = 2) and Collis 
(n = 1) fundoplications.
nineteen (95%) redo patients had clinical (n = 3) or 
clinical and endoscopic (n = 16) follow-up data, covering 
3.4 (IQR = 1.1–5.6) years. Endoscopically verified failure 
occurred in 6 (32%) after nissen (n = 4), Thal (n = 1), and 
thoracic Belsey Mark (n = 1) fundoplication. One patient 
Fig. 1. Patency rate of primary fundoplication in 269 patients; 5- and 10-year rate was 86% and 83%, respectively.
Fig. 2. Cumulative patency rate primary fundoplication in patients without any underlying disorder (n = 60; 5- and 10-year survival 
was 98% and 93%, respectively) and in patients with an underlying disorder (n = 200; 83% and 81%, respectively) (Logrank Mantel–Cox, 
healthy vs underlying disease, p = 0.08).
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with tracheoesophageal cleft died of tracheal bleeding 
1 month after redo-fundoplication. In patients with 
failed redo, underlying conditions included EA (n = 2) 
and heart disease, tracheoesophageal cleft, nI, and 
impaired esophageal motility one each. Median time 
from redo-fundoplication to failure was 5.2 (IQR = 2.7–
33) months.
Of the five survivors with failed redo, one patient 
with impaired esophageal motility underwent three 
further redo-fundoplications and her symptoms are 
currently manageable with medication, one patient 
with EA and anastomotic stricture underwent esopha-
geal resection, one with nI and one with EA have 
feeding jejunostomy, and one patient is managed 
medically. Overall, in 14 (74%) patients with redo-fun-
doplication, the clinical outcome was good.
OVERALL COnTROL OF GERD AFTER 
FUnDOPLICATIOn
Of the 269 patients with available follow-up data after 
primary or redo-fundoplication, effective control of 
GER was eventually achieved, with or without anti-
reflux medication, in 233(87%) patients (primary fun-
doplication n = 219, redo-fundoplication n = 14). Of the 
remaining 36 patients, moderate control of GER was 
achieved by medical treatment in 20, esophageal 
replacement was done in 3 with EA, 2 had feeding 
jejunostomy, and GER symptoms remain poorly con-
trolled in 10 (3%) patients (nI n = 7, RA n = 1, respira-
tory disorder n = 1, and heart disease n = 1).
PREDICTORS OF FAILED FUnDOPLICATIOn AnD 
UnFAVORABLE CLInICAL OUTCOME
Tested risk factors for failure of fundoplication, poor 
or moderate outcome, continued use of anti-reflux 
medication after fundoplication and non-healing of 
esophagitis included underlying disorder (EA, nI, 
heart disease or respiratory disorder, any disorder), 
age at surgery, fundoplication wrap technique, lapa-
roscopic technique, hiatoplasty, gastrostomy, failed 
fundoplication, postoperative complications such as 
dysphagia, inability to burp or vomit, changed diag-
nosis, and non-healing of esophagitis. Factors were 
first assessed in univariate logistic regression analy-
sis, and factors with risk ratios (RRs) of statistical sig-
nificance were further assessed in multivariate logistic 
analysis.
Statistically significant risk factors for fundoplica-
tion failure were EA risk ratio (RR) = 3.9 (95% confi-
dence interval (CI) = 1.3–11), p = 0.01; underlying 
disorder RR = 3.1(95% CI = 1.1–9.1), p = 0.04; and hiato-
plasty RR = 2.6 (95% CI = 1.1–6.6) in univariate analysis 
and hiatoplasty RR = 2.7 (95% CI 1.1–6.8), p = 0.03, in 
multivariate analysis.
Risk factors for unfavorable (poor or moderate) 
clinical control of GER were fundoplication failure 
RR = 18(95% CI = 8.0–39), p < 0.001; EA RR = 2.6 (95% 
CI = 1.3–5.0), p = 0.01; and non-healing of esophagitis 
RR = 2.7 (95% CI = 1.1–6.8), p = 0.03, in univariate anal-
ysis and fundoplication failure RR = 27(95% CI = 7.6–
93), p < 0.001, in multivariate analysis.
Independent predictors for continued use of anti-
reflux medication after fundoplication were failed fun-
doplication, EA, and non-healing of esophagitis 
RR = 2.4–9.0 (95% CI = 1.1–19), p = 0.03–0.001. If fun-
doplication was intact, only EA correlated with contin-
ued use of anti-reflux medication after fundoplication 
RR = 2.8 (95% CI = 1.4–5.8), p = 0.04. Risk factors for 
non-healed esophagitis, both in univariate and in mul-
tivariate analysis, were failed fundoplication and EA—
RR = 4.3–9.4 (95% CI = 1.2–47), p = 0.01–0.03, and 
RR = 5.1–11(95% CI = 1.2–61), p = 0.01–0.03, respectively.
Fig. 3. Cumulative patency rate of functioning primary fundoplication in healthy patients, in patients with esophageal atresia (EA), and 
in patients with neurological impairment (nI). The 5- and 10-year patency rate in healthy patients was 98% and 93%, respectively, in EA 
patients was 85% and 78%, respectively, and in nI patients was 80% and 76%, respectively (Logrank Mantel–Cox EA and nI vs healthy, 
p = 0.06).
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DISCUSSIOn
The main findings of this study were that (1) 80% of 
anti-reflux procedures were performed in order to 
control complications of GERD in children with asso-
ciated disorders; (2) primary fundoplication provided 
good long-term control of GERD symptoms in over 
80% of patients; (3) during long-term follow-up, 15% 
of primary fundoplications and 32% of redo-fundopli-
cations failed; (4) underlying disorder and EA 
increased the risk of fundoplication failure.
The main shortcoming of the study was its retro-
spective nature and extended study period, leading to 
large variations in the follow-up times. However, both 
clinical and endoscopic follow-up covered over 90% of 
the patients, and in 75% of the patients, follow-up 
exceeded 12 months.
These results reflect our approach to surgical treat-
ment of GERD in children. The great majority of the 
fundoplications and all esophagogastric disconnec-
tions were performed in children with significant 
associated disorders. Based on their cohort of over 
11,000 patients, McAteer et al. (11) recently criticized 
the excessive use of surgical treatment of GER in 
healthy infants aged below 6 months in whom GER is 
physiological. Our management of GER in healthy 
infants has been very conservative. During the 24-year 
study, only 10 healthy children aged below 12 months 
have undergone fundoplication.
Primary fundoplication controlled GERD symp-
toms effectively in more than 80% of our patients. 
These results concur with Fonkalsrud et al. (12) who in 
a large cohort of 7467 children reported good to excel-
lent results in 85%–95% of patients after 7.3 years. Here, 
fundoplication also promoted healing of esophagitis. 
Among the reasons for eventual poor outcome and 
unhealed esophagitis, fundoplication failure was, not 
surprisingly, a central risk factor. We found that after 
fundoplication, a substantial portion (29%) of patients, 
with or without failed fundoplication or persisting 
esophagitis, still used anti-reflux medication. This 
finding concurs with Lee et al. (13) who reported that 
4.5 years after nissen fundoplication, 58% of children 
used anti-reflux medication. Although fundoplication 
fails to wean all patients from anti-reflux medication, 
we think that control of symptoms and complications 
of GER with combination of fundoplication and medi-
cation is still of great value to a patient.
Postoperative dysphagia and inability to vomit are 
not related to the anti-reflux function of the fundopli-
cation but nevertheless produce significant discomfort 
to a patient. Post-fundoplication dysphagia has been 
reported in 10%–24% of patients, and endoscopic 
wrap dilatations have been required in 4%–12% of 
cases (4, 14–16). Although we could not assess the 
exact incidence of dysphagia, incidence of wrap dila-
tations among our patients was similar, that is, 4%. 
Post-fundoplication dysphagia may occur in 45% of 
patients with EA (17), but because dysphagia in EA is 
associated with impaired esophageal motility and 
anastomotic stenosis, we did not consider it as a fun-
doplication-related complication.
During the assessment of postoperative dysphagia, 
we discovered patients with impaired esophageal 
motility and eosinophilic esophagitis. Symptomatic 
esophageal dysmotility can be diagnosed before fun-
doplication but only in children who are old enough 
to cooperate in esophageal manometry. Eosinophilic 
esophagitis and reflux esophagitis may have similar 
symptoms, and histology and symptom in both types 
of esophagitis may respond well to anti-reflux medi-
cation. A typical feature of eosinophilic esophagitis is 
dysphagia (18, 19). In two of our patients, eosinophilic 
esophagitis was found in association with post-fun-
doplication dysphagia. It is possible that these two 
patients actually had eosinophilic esophagitis from 
the beginning, but they underwent fundoplication 
because preoperative biopsies and pathological acid 
reflux in pH monitoring pointed to reflux esophagitis. 
Dysphagia and eosinophilic esophagitis may have 
manifested after weaning from proton pump inhibi-
tors. We can speculate that with correct preoperative 
diagnosis of eosinophilic esophagitis, these patients 
could have been treated with medication without per-
forming unnecessary fundoplication. If esophagitis in 
a child responds poorly to proton pump inhibitors, a 
clinician should keep in mind eosinophilic esophagitis 
and look for typical endoscopic appearance and his-
tology. If the ascertained diagnose is eosinophilic 
esophagitis, the treatment of choice is medical treat-
ment with oral cortisone with dietary measures, 
whereas fundoplication may significantly aggravate 
dysphagia and is contraindicated.
Our overall long-term failure rate of primary fun-
doplications (15%) fell within the range of 12%–43% 
reported in the contemporary literature (4, 14–16, 20–
22). In this study and in a recent study by Lopez-
Fernandez et  al. (20), EA was a clear risk factor of 
fundoplication failure. Patients with EA often under-
went open fundoplication at an early age because of 
GER-induced anastomotic stenosis or apneic spells. In 
these situations, fundoplication is usually required 
without delay and the risk of later failure is of little 
significance. Control of acute EA-related GER symp-
toms with fundoplication usually sustains the patient 
over the first years of life. If fundoplication eventually 
fails, a redo operation is not always necessary because 
GER symptoms at later age may subside or they can 
be managed conservatively.
In concordance with Baerg et al. (22), we found that 
hiatoplasty was also a risk factor for fundoplication 
failure. Hiatoplasty may be considered an essential 
part of a classic fundoplication (2), but since the major-
ity of children have no hiatal hernia, routine dissection 
of crura followed by their suture apposition may not 
be necessary and minimal esophageal dissection may 
lead to less frequent fundoplication failures (23).
High failure rate with hiatoplasty may be associ-
ated with the fact that the patients in whom hiato-
plasty is performed have an underlying disease which 
aggravates the risk of fundoplication failure. This may 
be true in patients with EA, but in our series in which 
only 22% of patients had EA, hiatoplasty remained the 
strongest overall predictor of failure.
Laparoscopic and open fundoplication were com-
pared in two recent randomized studies. Pacilli et  al. 
(24) found no difference in failure rates during 4-years 
of follow-up (laparoscopic 20%, open 12.5%), whereas 
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in a study by Fyhn et al. (21), the difference during sim-
ilar follow-up was significant (laparoscopic 37%, open 
7%). In our series, laparoscopic technique was clearly 
preferred among children without underlying disor-
ders, which may explain the low failure rate.
nI has been considered a risk for failed fundoplica-
tion (1, 12), but this could not be confirmed in this 
study.
Overall, we performed redo-fundoplications in less 
than half of patients with failed fundoplication. Failure 
rate of redo-fundoplications was relatively high (33%) 
and some patients ended up with permanent feeding 
jejunostomy. Horwood et al (25) reported that in neu-
rologically impaired children, fundoplication with 
vagotomy and pyloroplasty resulted in lower need for 
revisional surgery (3%) than a standard fundoplica-
tion (17%) after 19.5 months of median follow-up. In 
nI patients with exceptionally severe complicated 
GERD and very limited ability to eat, we have used 
esophagogastric dissociation as a primary procedure 
in seven patients with satisfactory outcome. With a 
relatively low 9% redo-fundoplication rate in neuro-
logically impaired patients during the 24-year follow-
up, we, however, consider a standard fundoplication 
as the primary procedure in nI patients.
Anti-reflux surgery in pediatric patients focuses 
more often on prevention of life-threatening or disa-
bling complications of GERD in children with signifi-
cant associated disorders rather than to attenuate 
uncomfortable symptoms. Although anti-reflux sur-
gery in children includes failures and complications, 
the generally favorable outcome warrants its use in 
carefully selected patients.
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